8 results about "Ketosis" patented technology

Compositions and methods for providing a person with an exogenous and therapeutically effective supply of short chain fatty acids, chlorogenic acid, and, optionally, ketones are disclosed. The compositions include one or more short chain fatty acids (such as butyric acid, butyrate salts, propionic acid, propionate salts, acetic acid, or acetate salts); chlorogenic acid; and, optionally, one or more beta-hydroxybutyrate salts. The compositions and methods are useful for inducing ketosis and / or beta-oxidative activity in a subject. In addition, compositions that include concentrated forms of, and methods of using, chlorogenic acid (alone or in combination with short chain fatty acids and ketones) to induce ketogenesis in a subject are disclosed.

The present application relates to the technical field of oral liquid, in particular to a kind of oral liquid for preventing and treating perinatal energy metabolism disorder disease of dairy cow and preparation method thereof, it is characterized in that, the oral liquid for preventing and treating perinatal energy metabolism disorder disease of dairy cow is made of the following components, by weight parts: artemisia capillaris 200~300 parts, gardenia 150~200 parts, bupleurum 100~150 parts, polygonatum 50~100 parts, radix paeoniae alba 50~100 parts, liquorice 10~50 parts, nicotinic acid 1~10 parts, propylene glycol 200~300 parts, fructose diphosphate sodium 1~10 parts, pure water 200~400 parts.The oral liquid for preventing and treating perinatal energy metabolism disorder disease of dairy cow can prevent and treat ketosis, fatty liver and liver damage at the same time, comprehensively improve the constitution of new cow, improve immunity, improve physical indicators and reproductive performance, increase economic benefits.

This invention discloses an organic trace element complex for lactating dairy cows, comprising the following components in parts by weight: 40-70 parts of hydroxymethionine complex, 0.1-0.2 parts of sodium iodide, 30-45 parts of yeast selenium, 0.1-0.2 parts of cobalt sulfate, 10-25 parts of synergist, and 5-10 parts of carrier. This invention also discloses the preparation method and application of the above-mentioned organic trace element complex. When used in lactating dairy cows, the various hydroxymethionine complexes can effectively pass through the rumen to the small intestine and be absorbed through amino acid channels, meeting the needs of dairy cows for various trace elements during lactation. The synergistic effect of the various hydroxymethionine complexes and the synergist can improve the lactation performance of dairy cows, increase milk production, enhance the body's resistance, significantly reduce the incidence of mastitis and hoof diseases, and alleviate ketosis.

The invention relates to the technical field of livestock disease prevention and control early warning, and discloses a dairy cow ketosis prevention and control monitoring early warning method and system based on a perinatal period blood index, and the method comprises the steps: collecting a perinatal period dairy cow blood sample, and obtaining a metabolite feature set; obtaining health state information of the dairy cow; then obtaining a health state mark data set; outputting a ketosis prediction result of the currently detected dairy cow through the ketosis prediction model; the health change trend of the dairy cow is obtained, different individual intervention strategies are planned, the individual intervention strategies are accurately matched with the current health state stage of the dairy cow, and the optimal intervention scheme is obtained. According to the application, prospective, dynamic and precise prevention and control of ketosis can be realized, so that nutrition regulation and control are precisely matched with individual metabolic response, and the prospective, individualized and economical efficiency of prevention and control of perinatal metabolic diseases is remarkably improved.

This invention relates to the treatment of glucose transporter type 1 deficiency syndrome (Glut1-DS). In particular, the invention relates to specific medium-chain triglyceride compositions, enriched for C10 (decanoic acid), for use in treating movement disorders in Glut1-DS patients.

This invention relates to the treatment of glucose transporter type 1 deficiency syndrome (Glut1-DS). In particular, the invention relates to specific medium-chain triglyceride compositions, enriched for C10 (decanoic acid), for use in treating movement disorders in Glut1-DS patients.

Disclosed herein are compositions that include a combination of: (1) a non-xanthine CNS stimulant or nootropic; (2) a ketone body or ketone body precursor, such as beta-hydroxybutyrate (BHB) salt, BHB ester, BHB acid, acetoacetate salt, acetoacetate ester, acetoacetic acid, 1,3-butanediol, medium chain fatty acid, or ester of medium chain fatty acid; and (3) optionally a dietetically or pharmaceutically acceptable carrier. The composition may include a vasodilator. The composition may include a short or medium chain fatty acid or ester thereof in addition to or instead of the ketone body or ketone body precursor. The composition can provide enhanced cognitive flexibility, improved sustained attention, improved working memory, and neuroprotection in a mammal. The composition can also beneficially increase resting energy expenditure (resting metabolic rate), particularly when in a state of ketosis, enhancing fat loss principally through ketosis while promoting muscle formation and maintenance, as well as modulating lethargy / lightheadedness when entering a ketogenic state.

An object of the present invention is to make it possible to easily determine a presence or absence of ketosis and / or the possibility of ketosis in an animal on site or the like. Another object of the present invention is to provide an apparatus for performing the determination. A method for determining ketosis according to one embodiment of the present invention includes providing gas detection means with a gas generated from a body fluid collected from an animal (except for humans), and determining ketosis of the animal based on a composition of the gas generated from the body fluid using a response of the gas detection means to the gas generated from the body fluid.